Early users of the GlucoSense AI Blood Sugar Companion have shared positive feedback about its effectiveness in diabetes management. One user said, “I’m no longer in the dark and have regained control. Every newly diagnosed diabetic should be required to use this app.” Another commented, “These insights are incredible. I had no idea my levels were fluctuating so much until I started using GlucoSense.”
GlucoSense has conducted pilot programs with healthcare partners such as Wellstar and participated in industry conferences like ADCES 2025 to showcase the capabilities of its Companion tool. The company is also working with diabetes educators and health organizations to broaden access to its AI-driven support system.
Cofounders Jonathan Fitch and Cole Chalhub view the GlucoSense Companion as both a technical advancement and a way to focus on patient needs. They aim to combine machine learning, behavioral analysis, and educational resources to help people with diabetes manage their condition more effectively.
—
